149 related articles for article (PubMed ID: 38227097)
1. Association of Fusobacterium nucleatum infection with the clinicopathological characteristics in colorectal cancer patients.
Pang SW; Armon S; Chook JB; Chew J; Peh KB; Lim WW; Peh SC; Teow SY
Mol Biol Rep; 2024 Jan; 51(1):124. PubMed ID: 38227097
[TBL] [Abstract][Full Text] [Related]
2. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.
Flanagan L; Schmid J; Ebert M; Soucek P; Kunicka T; Liska V; Bruha J; Neary P; Dezeeuw N; Tommasino M; Jenab M; Prehn JH; Hughes DJ
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1381-90. PubMed ID: 24599709
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer.
Yamamoto S; Kinugasa H; Hirai M; Terasawa H; Yasutomi E; Oka S; Ohmori M; Yamasaki Y; Inokuchi T; Harada K; Hiraoka S; Nouso K; Tanaka T; Teraishi F; Fujiwara T; Okada H
J Gastroenterol Hepatol; 2021 Jul; 36(7):1869-1876. PubMed ID: 33242360
[TBL] [Abstract][Full Text] [Related]
4. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
5. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.
Lo CH; Wu DC; Jao SW; Wu CC; Lin CY; Chuang CH; Lin YB; Chen CH; Chen YT; Chen JH; Hsiao KH; Chen YJ; Chen YT; Wang JY; Li LH
J Biomed Sci; 2022 Oct; 29(1):88. PubMed ID: 36303164
[TBL] [Abstract][Full Text] [Related]
6. Fusobacterium nucleatum Load Correlates with KRAS Mutation and Sessile Serrated Pathogenesis in Colorectal Adenocarcinoma.
Takeda K; Koi M; Okita Y; Sajibu S; Keku TO; Carethers JM
Cancer Res Commun; 2023 Sep; 3(9):1940-1951. PubMed ID: 37772997
[TBL] [Abstract][Full Text] [Related]
7. Accuracy and Clinical Relevance of Intra-Tumoral
Datorre JG; de Carvalho AC; Dos Reis MB; Dos Reis M; Matsushita M; Santos F; Guimarães DP; Reis RM
Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054281
[TBL] [Abstract][Full Text] [Related]
8. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
[TBL] [Abstract][Full Text] [Related]
9.
Chen S; Su T; Zhang Y; Lee A; He J; Ge Q; Wang L; Si J; Zhuo W; Wang L
Gut Microbes; 2020 May; 11(3):511-525. PubMed ID: 31910722
[TBL] [Abstract][Full Text] [Related]
10. Association between Fusobacterium nucleatum and patient prognosis in metastatic colon cancer.
Lee JB; Kim KA; Cho HY; Kim D; Kim WK; Yong D; Lee H; Yoon SS; Han DH; Han YD; Paik S; Jang M; Kim HS; Ahn JB
Sci Rep; 2021 Oct; 11(1):20263. PubMed ID: 34642332
[TBL] [Abstract][Full Text] [Related]
11. Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study.
Eisele Y; Mallea PM; Gigic B; Stephens WZ; Warby CA; Buhrke K; Lin T; Boehm J; Schrotz-King P; Hardikar S; Huang LC; Pickron TB; Scaife CL; Viskochil R; Koelsch T; Peoples AR; Pletneva MA; Bronner M; Schneider M; Ulrich AB; Swanson EA; Toriola AT; Shibata D; Li CI; Siegel EM; Figueiredo J; Janssen KP; Hauner H; Round J; Ulrich CM; Holowatyj AN; Ose J
Clin Colorectal Cancer; 2021 Sep; 20(3):e165-e172. PubMed ID: 33935016
[TBL] [Abstract][Full Text] [Related]
12. Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade.
Chen Y; Peng Y; Yu J; Chen T; Wu Y; Shi L; Li Q; Wu J; Fu X
Oncotarget; 2017 May; 8(19):31802-31814. PubMed ID: 28423670
[TBL] [Abstract][Full Text] [Related]
13. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
[TBL] [Abstract][Full Text] [Related]
14. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients.
Li YY; Ge QX; Cao J; Zhou YJ; Du YL; Shen B; Wan YJ; Nie YQ
World J Gastroenterol; 2016 Mar; 22(11):3227-33. PubMed ID: 27004000
[TBL] [Abstract][Full Text] [Related]
15. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer.
Osman MA; Neoh HM; Ab Mutalib NS; Chin SF; Mazlan L; Raja Ali RA; Zakaria AD; Ngiu CS; Ang MY; Jamal R
Sci Rep; 2021 Feb; 11(1):2925. PubMed ID: 33536501
[TBL] [Abstract][Full Text] [Related]
16. [Advances on the treatment of
Wang H; Hou X; Liu J; Yang C
Sheng Wu Gong Cheng Xue Bao; 2023 Sep; 39(9):3670-3680. PubMed ID: 37805845
[No Abstract] [Full Text] [Related]
17. Fusobacterium nucleatum-triggered neutrophil extracellular traps facilitate colorectal carcinoma progression.
Kong X; Zhang Y; Xiang L; You Y; Duan Y; Zhao Y; Li S; Wu R; Zhang J; Zhou L; Duan L
J Exp Clin Cancer Res; 2023 Sep; 42(1):236. PubMed ID: 37684625
[TBL] [Abstract][Full Text] [Related]
18. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.
Chen WD; Zhang X; Zhang YP; Yue CB; Wang YL; Pan HW; Zhang YL; Liu H; Zhang Y
Curr Med Sci; 2022 Jun; 42(3):538-547. PubMed ID: 35678912
[TBL] [Abstract][Full Text] [Related]
19. Microbiota Profile and Impact of
de Carvalho AC; de Mattos Pereira L; Datorre JG; Dos Santos W; Berardinelli GN; Matsushita MM; Oliveira MA; Durães RO; Guimarães DP; Reis RM
Front Oncol; 2019; 9():813. PubMed ID: 31555583
[TBL] [Abstract][Full Text] [Related]
20. Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism.
Ou S; Wang H; Tao Y; Luo K; Ye J; Ran S; Guan Z; Wang Y; Hu H; Huang R
Front Cell Infect Microbiol; 2022; 12():1020583. PubMed ID: 36523635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]